Delayed recovery of thyrotropin responsiveness after radioactive iodine therapy for hyperthyroidism

American Journal of the Medical Sciences

Volumn 319, Issue 6, 2000, Pages 376-379

  Albert, Stewart G ^a   Goodgold, Henry M ^a   Chehade, Joe ^a   Kim, Joohee ^a  

^a SAINT LOUIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Graves disease; Hyperthyroidism; Radioactive iodine therapy; Thyroid stimulating hormone (TSH); Thyrotropin)

Indexed keywords

PERTECHNETIC ACID TC 99M; RADIOACTIVE IODINE; THYROTROPIN;

ADULT; AGED; ARTICLE; EUTHYROIDISM; FEMALE; GRAVES DISEASE; HORMONE RESPONSE; HUMAN; HYPERTHYROIDISM; HYPOTHYROIDISM; MAJOR CLINICAL STUDY; MALE; THYROID ADENOMA; THYROID FUNCTION; THYROID HORMONE BLOOD LEVEL; TOXIC GOITER;

EID: 0034131027     PISSN: 00029629     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000441-200006000-00006     Document Type: Article

References (9)

1. Vagenakis AG, Braverman LE, Azizi F, et al. Recovery of pituitary thyrotropic function after withdrawal of prolonged thyroid-suppression therapy. N Eng J Med 1975;293:681-4.
2. Krugman LG, Hershman JM, Chopra IJ, et al. Patterns of recovery of the hypothalamic- pituitary-thyroid axis in patients taken off chronic thyroid therapy. J Clin Endocrinol Metab 1975;41:70-80.
3. Nicoloff JT, Spencer CA. The use and misuse of the sensitive thyrotropin assays. J Clin Endocrinol Metab 1990;71: 553-8.
4. Uy HL, Reasner CA, Samuels MH. Pattern of recovery of the hypothalamic-pituitary-thyroid axis following radioactive iodine therapy in patients with Graves' disease. Am J Med 1995;99:173-9.
5. Ross DS, Daniels GH, Gouveia D. The use and limitations of a chemiluminescent thyrotropin assay as a single thyroid function test in an out-patient endocrine clinic. J Clin Endocrinol Metab 1990;71:764-9.
6. Helfand M Redfern CC. Screening for thyroid disease-an update. Ann Intern Med 1998;129:144-58.
7. Sanchez-Franco F, Garcia MD, Cacicedo L, et al. Transient lack of thyrotropin (TSH) response to thyrotropin-releasing hormone (TRH) in treated hyperthyroid patients with normal or low serum Thyroxine (T4) and triiodothyronine (T3). J Clin Endocrinol Metab 1974;38:1098-102.
8. Davis JRE, Black EG, Sheppard MC. Evaluation of a sensitive chemiluminescent assay for TSH in the follow-up of treated thyrotoxicosis. Clin Endocrinol 1987;27:563-70.
9. Davies PH, Franklyn JA, Daykin J, et al. The significance of TSH values measured in a sensitive assay in the follow-up of hyperthyroid patients treated with radioiodine. J Clin Endocrinol Metab 1992;74:1189-92.